Asset
PERFLUTREN
Lantheus Holdings Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (4)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT00625365 | phase4 | completed | 2008-02-01 | 2009-05-01 | Lantheus Medical Imaging | A Prospective, Phase IV, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical Practice |
| NCT00918866 | phase4 | completed | 2009-07-01 | 2009-12-01 | Lantheus Medical Imaging | A Study of Commercial DEFINITY® to Monitor the Effects of the Heart's Pulmonary Artery Pressure |
| NCT03571672 | phase3 | completed | 2018-10-24 | 2019-08-30 | Lantheus Medical Imaging | DEF-314 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY |
| NCT03719612 | phase3 | completed | 2018-12-28 | 2020-01-09 | Lantheus Medical Imaging | DEF-315 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY |
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| NDA 021064 | NDA | LANTHEUS MEDICAL IMAGING INC |
Marketed products (2)
- DEFINITY
- DEFINITY RT